No evidence of attenuation of placental insulin-stimulated Akt phosphorylation and amino acid transport in obesity and gestational diabetes mellitus.

Pregnancies complicated by obesity and/or gestational diabetes (GDM) are associated with peripheral insulin resistance, however the insulin responsiveness of the placenta in these pregnancy complications remains largely unknown. We tested the hypothesis that primary human trophoblast cells and placental villous explants will be insulin responsive characterized by amino acid transport, Akt and Erk activity with maternal obesity and/or GDM.We evaluated term placentas from women with normal body mass index (BMI) (NORMAL, n=15), obesity (OB, n=11), normal BMI with GDM (N-GDM, n=11) and obesity with GDM (OB-GDM, n=11). In a subgroup, primary human trophoblast cells (PHT) were isolated and in an independent subgroup placental villous explants were exposed to varying concentrations of insulin. Amino acid transport capacity and insulin signaling activity were determined. Insulin significantly increased amino acid transport activity to a similar degree in PHT cells isolated from NORMAL (+21%), N-GDM (+38%), OB (+37%) and OB-GDM (+35%) pregnancies. Insulin increased Akt and Erk phosphorylation in PHT cells (3-fold) and in villous explants (2-fold) in all groups to a similar degree.In contrast to the peripheral maternal insulin resistance commonly associated with obesity and/or GDM we found that the placenta is insulin sensitive in these pregnancy complications. We suggest that elevated maternal insulin levels in pregnancies complicated by obesity and/or GDM promote critical placental functions, including amino acid transport. Insulin-stimulated placental nutrient delivery may contribute to the increased risk of fetal overgrowth and adiposity in these pregnancies. Moreover, our findings may inform efforts to optimize insulin regimens for women with GDM.

[1]  Yoichi Kobayashi,et al.  Leaner Women with Impaired Insulin Secretion Accounts for about 40% of Gestational Diabetes Mellitus in Japan , 2019, Journal of pregnancy.

[2]  S. Wesolowski,et al.  Normalizing adiponectin levels in obese pregnant mice prevents adverse metabolic outcomes in offspring , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  J. Bowe,et al.  Placental peptides regulating islet adaptation to pregnancy: clinical potential in gestational diabetes mellitus , 2018, Current opinion in pharmacology.

[4]  Xilin Yang,et al.  Roles of insulin resistance and beta cell dysfunction in macrosomia among Chinese women with gestational diabetes mellitus. , 2018, Primary care diabetes.

[5]  M. Landon,et al.  Oral Agents for the Treatment of Gestational Diabetes , 2018, Current Diabetes Reports.

[6]  L. Sobrevia,et al.  Insulin therapy and its consequences for the mother, foetus, and newborn in gestational diabetes mellitus. , 2018, Biochimica et biophysica acta. Molecular basis of disease.

[7]  S. Sureshchandra,et al.  Inflammatory Determinants of Pregravid Obesity in Placenta and Peripheral Blood , 2018, Front. Physiol..

[8]  Yunxian Yu,et al.  The association of gestational diabetes mellitus with fetal birth weight. , 2018, Journal of diabetes and its complications.

[9]  W. Henrich,et al.  Maternal overweight is not an independent risk factor for increased birth weight, leptin and insulin in newborns of gestational diabetic women: observations from the prospective ‘EaCH’ cohort study , 2018, BMC Pregnancy and Childbirth.

[10]  V. Winn,et al.  Placental lipoprotein lipase activity is positively associated with newborn adiposity. , 2018, Placenta.

[11]  M. Iwashita,et al.  Increased maternal insulin resistance promotes placental growth and decreases placental efficiency in pregnancies with obesity and gestational diabetes mellitus , 2018, The journal of obstetrics and gynaecology research.

[12]  Julie Brown,et al.  Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews. , 2016, The Cochrane database of systematic reviews.

[13]  ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus. , 2018, Obstetrics and gynecology.

[14]  T. Powell,et al.  Placental Nutrient Transport in Gestational Diabetic Pregnancies , 2017, Front. Endocrinol..

[15]  T. Powell,et al.  Glyburide treatment in gestational diabetes is associated with increased placental glucose transporter 1 expression and higher birth weight. , 2017, Placenta.

[16]  L. Mack,et al.  Gestational Diabetes: Diagnosis, Classification, and Clinical Care. , 2017, Obstetrics and gynecology clinics of North America.

[17]  G. Neal-Perry,et al.  Long-term consequences of obesity on female fertility and the health of the offspring , 2017, Current opinion in obstetrics & gynecology.

[18]  M. Nitert,et al.  Review: Placental transport and metabolism of energy substrates in maternal obesity and diabetes. , 2017, Placenta.

[19]  K. Shankar,et al.  Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child , 2017, British Medical Journal.

[20]  K. Flegal,et al.  Trends in Obesity Among Adults in the United States, 2005 to 2014. , 2016, JAMA.

[21]  L. Myatt,et al.  Mitochondrial function and glucose metabolism in the placenta with gestational diabetes mellitus: role of miR-143. , 2016, Clinical science.

[22]  E. Mcclure,et al.  Diabetes during Pregnancy in Low- and Middle-Income Countries , 2016, American Journal of Perinatology.

[23]  T. Powell,et al.  Protein expression of fatty acid transporter 2 is polarized to the trophoblast basal plasma membrane and increased in placentas from overweight/obese women. , 2016, Placenta.

[24]  T. Powell,et al.  TNF-α stimulates System A amino acid transport in primary human trophoblast cells mediated by p38 MAPK signaling , 2015, Physiological reports.

[25]  F. Rosario,et al.  Adiponectin supplementation in pregnant mice prevents the adverse effects of maternal obesity on placental function and fetal growth , 2015, Proceedings of the National Academy of Sciences.

[26]  M. Namba,et al.  Insulin resistance and β-cell function influence postprandial blood glucose levels in Japanese patients with gestational diabetes mellitus , 2015, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[27]  Y. Kanai,et al.  Increased placental nutrient transport in a novel mouse model of maternal obesity with fetal overgrowth , 2015, Obesity.

[28]  S. Hauguel-de Mouzon,et al.  Identification of early transcriptome signatures in placenta exposed to insulin and obesity. , 2015, American journal of obstetrics and gynecology.

[29]  N. Sattar,et al.  Impact of maternal obesity on perinatal and childhood outcomes. , 2015, Best practice & research. Clinical obstetrics & gynaecology.

[30]  T. Powell,et al.  Increased glucose and placental GLUT-1 in large infants of obese nondiabetic mothers. , 2015, American journal of obstetrics and gynecology.

[31]  V. Harris,et al.  Protein detection by Simple Western™ analysis. , 2015, Methods in molecular biology.

[32]  P. Catalano,et al.  Placental growth response to maternal insulin in early pregnancy. , 2015, The Journal of clinical endocrinology and metabolism.

[33]  F. Hu,et al.  The Epidemiology of Obesity: A Big Picture , 2015, PharmacoEconomics.

[34]  T. Powell,et al.  The Role of Placental Nutrient Sensing in Maternal-Fetal Resource Allocation1 , 2014, Biology of reproduction.

[35]  Shin Y. Kim,et al.  Prevalence Estimates of Gestational Diabetes Mellitus in the United States, Pregnancy Risk Assessment Monitoring System (PRAMS), 2007–2010 , 2014, Preventing chronic disease.

[36]  P. Catalano Trying to understand gestational diabetes , 2014, Diabetic medicine : a journal of the British Diabetic Association.

[37]  S. Weintraub,et al.  Adiponectin inhibits insulin function in primary trophoblasts by PPARα-mediated ceramide synthesis. , 2014, Molecular endocrinology.

[38]  T. Powell,et al.  Interleukin-1β inhibits insulin signaling and prevents insulin-stimulated system A amino acid transport in primary human trophoblasts , 2013, Molecular and Cellular Endocrinology.

[39]  D. Coustan,et al.  Gestational diabetes mellitus. , 2013, Clinical chemistry.

[40]  F. Rosario,et al.  Activation of placental mTOR signaling and amino acid transporters in obese women giving birth to large babies. , 2013, The Journal of clinical endocrinology and metabolism.

[41]  T. Powell,et al.  Regulation of Nutrient Transport across the Placenta , 2012, Journal of pregnancy.

[42]  Claudio Nicolás Valencia,et al.  Gestational diabetes and pre‐pregnancy overweight: Possible factors involved in newborn macrosomia , 2012, The journal of obstetrics and gynaecology research.

[43]  C. Cobelli,et al.  Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy , 2010, Diabetologia.

[44]  M. Stridsberg,et al.  Insulin Resistance, a Link between Maternal Overweight and Fetal Macrosomia in Nondiabetic Pregnancies , 2010, Hormone Research in Paediatrics.

[45]  M. Lappas,et al.  Diabetes and obesity during pregnancy alter insulin signalling and glucose transporter expression in maternal skeletal muscle and subcutaneous adipose tissue. , 2010, Journal of molecular endocrinology.

[46]  T. Powell,et al.  Full-Length Adiponectin Attenuates Insulin Signaling and Inhibits Insulin-Stimulated Amino Acid Transport in Human Primary Trophoblast Cells , 2010, Diabetes.

[47]  T. Powell,et al.  Regulation of amino acid transporters by glucose and growth factors in cultured primary human trophoblast cells is mediated by mTOR signaling. , 2009, American journal of physiology. Cell physiology.

[48]  G. Desoye,et al.  Insulin and the IGF system in the human placenta of normal and diabetic pregnancies , 2009, Journal of anatomy.

[49]  S. Hauguel-de Mouzon,et al.  Fetuses of Obese Mothers Develop Insulin Resistance in Utero , 2009, Diabetes Care.

[50]  M. Lappas,et al.  Defective insulin signaling in placenta from pregnancies complicated by gestational diabetes mellitus. , 2009, European journal of endocrinology.

[51]  P. Damm,et al.  Placental triglyceride accumulation in maternal type 1 diabetes is associated with increased lipase gene expression Published, JLR Papers in Press, August 29, 2006. , 2006, Journal of Lipid Research.

[52]  A. Alonso,et al.  Effects of gestational diabetes mellitus on proteins implicated in insulin signaling in human placenta , 2006, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[53]  B. Johansson,et al.  Hormonal regulation of glucose and system A amino acid transport in first trimester placental villous fragments. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

[54]  T. Powell,et al.  Glucose transporter isoform 4 is expressed in the syncytiotrophoblast of first trimester human placenta. , 2005, Human reproduction.

[55]  T. Powell,et al.  Triglyceride hydrolase activities and expression of fatty acid binding proteins in the human placenta in pregnancies complicated by intrauterine growth restriction and diabetes. , 2004, The Journal of clinical endocrinology and metabolism.

[56]  B. Johansson,et al.  Leptin stimulates the activity of the system A amino acid transporter in human placental villous fragments. , 2003, The Journal of clinical endocrinology and metabolism.

[57]  T. Powell,et al.  Alterations in the activity of placental amino acid transporters in pregnancies complicated by diabetes. , 2002, Diabetes.

[58]  T. Powell,et al.  Placental glucose transport in gestational diabetes mellitus. , 2001, American journal of obstetrics and gynecology.

[59]  T. Powell,et al.  Placental glucose transport and GLUT 1 expression in insulin-dependent diabetes. , 1999, American journal of obstetrics and gynecology.

[60]  B. Malomed,et al.  A new form of liquid matter: Quantum droplets , 2020, Frontiers of Physics.

[61]  Y. Omori,et al.  Insulin-receptor kinase is enhanced in placentas from non-insulin-dependent diabetic women with large-for-gestational-age babies. , 1994, Diabetes research and clinical practice.

[62]  S. Fisher,et al.  Amino acid transport by the cultured human placental trophoblast: effect of insulin on AIB transport. , 1992, The American journal of physiology.

[63]  J. Tavaré,et al.  Differential expression of the receptors for epidermal growth factor and insulin in the developing human placenta. , 1989, Cellular signalling.

[64]  H. Kliman,et al.  Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. , 1986, Endocrinology.

[65]  D. Coustan,et al.  Criteria for screening tests for gestational diabetes. , 1982, American journal of obstetrics and gynecology.

[66]  B. Metzger,et al.  Carbohydrate metabolism in pregnancy. XVII. Diurnal profiles of plasma glucose, insulin, free fatty acids, triglycerides, cholesterol, and individual amino acids in late normal pregnancy. , 1981, American journal of obstetrics and gynecology.

[67]  B. Metzger,et al.  Carbohydrate metabolism in pregnancy: XVII. Diurnal profiles of plasma glucose, insulin, free fatty acids, triglycerides, cholesterol, and individual amino acids in late normal pregnancy☆ , 1981 .

[68]  J. Whitsett,et al.  Characteristics of the microvillus brush border of human placenta: insulin receptor localization in brush border membranes. , 1978, Endocrinology.

[69]  L. Jarett,et al.  Nonuniform Distribution and Grouping of Insulin Receptors on the Surface of Human Placental Syncytial Trophoblast , 1978, Diabetes.

[70]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.